ISG15, a protein containing two ubiquitin-like domains, is an interferon-stimulated gene product that functions in antiviral response and is conjugated to various cellular proteins (ISGylation) upon interferon stimulation. ISGylation occurs via a pathway similar to the pathway for ubiquitination that requires the sequential action of E1/E2/E3: The E1 (UBE1L), E2 (UbcH8), and E3 (Efp/Herc5) enzymes for ISGylation have been hitherto identified. In this study, we identified six novel candidate target proteins for ISGylation by a proteomic approach. Four candidate target proteins were demonstrated to be ISGylated in UBE1L-and UbcH8-dependent manners, and ISGylation of the respective target proteins was stimulated by Herc5. In addition, Herc5 was capable of binding with the respective target proteins. Thus, these results suggest that Herc5 functions as a general E3 ligase for protein ISGylation.
Introduction
Type I interferon functions in cellular antiviral response via induction of genes called interferon-stimulated genes (ISGs) [1] . Recently, ISG15, one of the ISGs, was found to function as an antiviral protein against Sindbis virus and HIV-1 [2, 3] although the molecular mechanism remains unknown. ISG15 contains two ubiquitin-like domains and belongs to the ubiquitin-like protein family. The expression of ISG15 is induced by interferon stimulation and ISG15 is conjugated to various cellular proteins (ISGylation) in a manner similar to ubiquitination that is catalyzed by the sequential action of E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme) and E3 (ubiquitin ligase) [4, 5] . Target proteins modified with ISG15 [6] [7] [8] , the E1 (UBE1L) and E2 (UbcH8) enzymes functioning in ISGylation [9] [10] [11] , and a de-ISGylating enzyme (UBP43) [12] have been identified, but biological consequences of ISGylation have been studied in only a few cases [13] [14] [15] . Recently, Efp and Herc5 have been reported to function as E3 ligases for ISGylation [16, 17] , but there seems to be a difference in function between Efp and Herc5 because Herc5, but not Efp, influences the ISGylation status of whole cellular proteins [16, 17] .
In this study, we identified six novel candidate target proteins for ISGylation and confirmed that four identified proteins, XPD (ERCC2), STK38, RGS3 isoform 1 and α-tubulin, are actually ISGylated in UBE1L-and UbcH8-dependent manners. In addition, we found that Herc5 is capable of binding with and stimulating ISGylation of the respective 3 novel target proteins.
Materials and methods
Cell culture and transfection. HeLa cells were cultured in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% heat-inactivated calf serum (Hyclone). Transfection was performed according to the standard calcium precipitation protocol.
Plasmid construction. The mammalian expression plasmids of ISG15, UBE1L, and UbcH8 were generated as described previously [15] . The open-reading frames of human XPD (ERCC2), STK38, RGS3 isoform 1, α-tubulin, and Herc5 were amplified by PCR. All constructs were verified by DNA sequencing. To generate the expression plasmids, the PCR fragments were subcloned into pCI-neo-3Flag and pCI-neo-2S vectors that had been generated by inserting oligonucleotides encoding three repeats of Flag-tag sequence and two repeats of S-peptide sequence, respectively, into the pCI-neo mammalian expression vector (Promega). To generate the expression plasmid of Efp, the open reading frame of human Efp was cut from the Myc-Efp plasmid that had been constructed as described previously [18] and was subcloned into the pCI-neo-2S vector.
Isolation of ISGylated proteins. HeLa cells that had been transiently transfected with
Flag-tagged ISG15, S-tagged UBE1L and S-tagged UbcH8 expression plasmids and cultured for 36 h were washed with ice-cold phosphate-buffered saline and lysed with RIPA buffer 4 containing 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Nonidet P-40, 1 mM DTT, and 5 mM N-ethylmaleimide. The cell lysate was sonicated for 3 s and the debris was removed by centrifugation. The resulting supernatant was incubated with anti-Flag M2 antibody-immobilized agarose (Sigma), and the resulting immunoprecipitate was washed three times with RIPA buffer, followed by washing three times with a buffer containing 20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.2% Nonidet P-40, and 10% glycerol. The materials bound to the beads were eluted with 3 x Flag peptide (Sigma) (200 µg/ml) and subjected to acetone precipitation.
SDS-PAGE and Western blotting. Isolated ISGylated proteins were separated by
SDS-PAGE and stained with Coomassie Brilliant Blue. Western blotting was performed as described previously [13] .
Peptide mass fingerprinting. Peptide mass fingerprinting was performed as described previously [19] Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% Nonidet P-40, 10% glycerol, and 1 mM phenylmethylsulfonyl fluoride, and the supernatant of the cell lysate was subjected to affinity purification using S-protein-immobilized agarose beads (Novagen). The resulting precipitate was washed three times with buffer B and subjected to Western blotting.
Results and discussion

Identification of proteins modified with ISG15
To determine the physiological meanings of ISGylation, it is necessary to identify proteins that are modified with ISG15. We carried out a proteomic analysis of ISGylated proteins. Flag-tagged ISG15, S-tagged UBE1L, and S-tagged UbcH8 were expressed in HeLa cells, and ISGylated proteins were isolated from the cell extract by immunoprecipitation with anti-Flag tag antibody-immobilized agarose beads and subsequent elution with 3 x Flag peptide. The isolated proteins were separated by SDS-PAGE and stained with Coomassie
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Brilliant Blue (Fig. 1) . The separated protein bands were subjected to peptide mass fingerprinting and ten candidate target proteins for ISGylation were identified (Table 1) .
Among them, six proteins are novel candidate target proteins that have not been reported. 
Herc5 stimulates ISGylation of novel target proteins
Efp and Herc5 have been reported to be E3 ligases for ISGylation [16, 17] , although they also function as ubiquitin E3 ligases [18, 20] . We carried out experiments to determine which 7 E3 ligase stimulates ISGylation of four target proteins newly identified in this study, XPD (ERCC2), STK38, RGS3 isoform 1 and α-tubulin. First, we constructed mammalian expression plasmids of Efp and Herc5 and expressed them together with T7-tagged ISG15, S-tagged UBE1L, and S-tagged UbcH8 in HeLa cells. The extracts of transfected cells were subjected to Western blotting with anti-T7 tag and anti-S peptide antibodies (Fig. 3) .
Consistent with previous reports [16, 17] 
Herc5 is capable of binding with novel target proteins for ISGylation
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It is well known that the ubiquitin E3 ligase recognizes or binds with target proteins for ubiquitination [4] . We next determined whether Herc5 is capable of binding with four target proteins, XPD (ERCC2), STK38, RGS3 isoform 1 and α-tubulin. The respective Flag-tagged target proteins were expressed together with S-tagged Herc5 or Efp in HeLa cells, and the extracts of transfected cells were subjected to affinity purification using S-protein-immobilized agarose beads and then to Western blotting with anti-Flag tag and anti-S peptide antibodies (Fig. 5 ). Herc5 was found to bind with each of the four target proteins, while Efp was found to bind weakly only with XPD (ERCC2).
In conclusion, we identified six novel target proteins for ISGylation and found that ISGylation of XPD (ERCC2), STK38, RGS3 isoform 1 and α-tubulin is catalyzed by three enzymes, UBE1L, UbcH8, and Herc5. These results agree well with results of a previous study showing that Herc5 is an accelerator of a broad range of ISG15 conjugation [17] . The construction of an in vitro ISGylation system containing recombinant Herc5 together with ISG15, UBE1L and UbcH8 will verify the speculation that Herc5 functions as a general E3
ligase for protein ISGylation. Previously reported [7, 8] .
